(Q56997440)

English

Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study

scientific article published on 13 July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

methylprednisolone

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Delannoy A

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Lhéritier V

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Castaigne S

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Rigal-Huguet F

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Raffoux E

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Garban F

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Legrand O

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bologna S

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Dubruille V

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Turlure P

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Reman O

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Delain M

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Isnard F

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Coso D

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Raby P

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Buzyn A

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Caillères S

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Darre S

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Fohrer C

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sonet A

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bilhou-Nabera C

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Béné MC

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Dombret H

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Berthaud P

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Thomas X

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

0 references

publication date

13 July 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1526-1532

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404320

0 references

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404320

21 January 2018

Identifiers

10.1038/SJ.LEU.2404320

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838024%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56997440&oldid=2166977852"